This section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article content
Sign In or Create an Account
or View more offersArticle content
Renewal strengthens Sequenex’s position as an integrated software product development partner for the medical device industry
Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content
ATLANTA — Sequenex Corp. today announced the renewal of its ISO 13485:2016 quality management system certification. The certification is valid through July 9, 2029, and covers Sequenex’s quality management system for the “Design and Development of Software for use in Medical Devices.”
Article content
ISO 13485:2016 is an internationally recognized quality management system standard for organizations involved in the design, development and manufacture of medical devices and related services.
Article content
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Sequenex first achieved ISO 13485:2016 certification in 2023 and has maintained its certification continuously. The renewal follows an independent assessment of the company’s quality management system and confirms its continued conformity with the requirements of the standard.
Article contentArticle content
“Medical device software requires more than working code,” said John Krlin, chief technology officer of Sequenex. “Requirements, risks, design decisions, changes and test evidence must remain connected throughout the software lifecycle. Our renewed certification reflects the quality management foundation that enables us to maintain that discipline.”
Article content
Software increasingly shapes how medical devices connect, exchange data and support clinical workflows. Sequenex helps medical device companies address this need by combining specialized engineering, development under the controls of its ISO 13485-certified quality management system, and software lifecycle documentation designed to support customers’ Design History Files and regulatory activities.
Article content
“Hardware-focused medical device companies need a software partner that understands the complete product—not simply an engineering vendor,” said Amy Neckermann, chief executive officer of Sequenex. “We bring engineering, quality processes and documentation together so customers can advance their software and device in parallel while reducing gaps, rework and development risk.”
Article content
Sequenex works closely with customers and their quality teams to define the software lifecycle documentation appropriate to each program, which may include requirements, design documentation, risk management inputs, traceability, verification and validation evidence, and release documentation.
Article content
About Sequenex
Article content
Sequenex accelerates software delivery for connected medical devices, wearables, biosensors, CGM and SaMD through custom development, the NEX™ prebuilt software platform and medtech-focused engineering resourcing. Its ISO 13485-certified quality management system and software lifecycle documentation support help customers reduce development time, rework and risk from proof of concept through commercialization.
Article content
For more information, visit https://sequenex.com.
Article contentArticle contentArticle contentArticle contentView source version on businesswire.com: Article content
https://www.businesswire.com/news/home/20260902889259/en/
Article contentArticle content
Contacts
Article contentThis advertisement has not loaded yet.Trending
Posthaste: Markets predict three Bank of Canada rates hikes are coming and some economists agree
News
Which states stand to suffer most in escalated U.S.-Canada trade war?
Economy- Story continues belowThis advertisement has not loaded yet, but your article continues below.
Here’s how a growing pool of Canadians are paying off their mortgages
Mortgages
Can Tom afford to retire by 63 with a $1.16 million portfolio?
Family Finance
Smaller Toronto condos losing value twice as fast: report
Real Estate
